Umar Y. Raja

Islamabad, IS, Pakistan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

The efficacyand safety of once weekly injectable semaglutide (Ozempic) among patients with Type 2 diabete sintertiary care hospital: A Retrospective Study.

The efficacyand safety of once weekly injectable semaglutide (Ozempic) among patients with Type 2 diabete sintertiary care hospital: A Retrospective Study.

Journal: JPMA. The Journal of the Pakistan Medical Association

Published: June 09, 2026

Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan.

Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan.

Journal: Diabetes, obesity & metabolism

Published: May 05, 2026

Comparative efficacy and safety of finerenone in diabetic kidney disease: a meta-analysis of Asian and non-Asian populations.

Comparative efficacy and safety of finerenone in diabetic kidney disease: a meta-analysis of Asian and non-Asian populations.

Journal: BMC nephrology

Published: July 28, 2025

Multicenter, Retrospective, observational study to evaluate the real-world use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in the Pakistani population with Type-2 diabetes (T2D).

Multicenter, Retrospective, observational study to evaluate the real-world use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in the Pakistani population with Type-2 diabetes (T2D).

Journal: Pakistan journal of medical sciences

Published: September 30, 2024

Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial.

Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial.

Journal: BMC endocrine disorders

Published: June 27, 2022

Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study.

Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study.

Journal: BMC endocrine disorders

Published: April 12, 2022

Dapagliflozin: The outcome of use as add-on therapy in real-life clinical setting -An Audit.

Dapagliflozin: The outcome of use as add-on therapy in real-life clinical setting -An Audit.

Journal: JPMA. The Journal of the Pakistan Medical Association

Published: September 28, 2021

Essential diagnostics and devices in primary care diabetes.

Essential diagnostics and devices in primary care diabetes.

Journal: JPMA. The Journal of the Pakistan Medical Association

Published: September 28, 2021

Efficacy and Safety of Dulaglutide in Type 2 Diabetes Patients in Endocrinology Clinics of Islamabad, Pakistan.

Efficacy and Safety of Dulaglutide in Type 2 Diabetes Patients in Endocrinology Clinics of Islamabad, Pakistan.

Journal: Indian journal of endocrinology and metabolism

Published: September 16, 2021

Weight and Body Mass Index for Predicting Thyroxine Dose in Primary Hypothyroidism.

Weight and Body Mass Index for Predicting Thyroxine Dose in Primary Hypothyroidism.

Journal: Cureus

Published: June 17, 2021

Asymptomatic urinary tract infections and associated risk factors in Pakistani Muslim type 2 diabetic patients.

Asymptomatic urinary tract infections and associated risk factors in Pakistani Muslim type 2 diabetic patients.

Journal: BMC infectious diseases

Published: January 27, 2021

Thyroid Storm, a Mimicker of Guillain-Barre Syndrome: A Case Report.

Thyroid Storm, a Mimicker of Guillain-Barre Syndrome: A Case Report.

Journal: Cureus

Published: September 24, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026